Sanara outlines Q2 2026 net revenue of $28.5M-$29.5M while reaffirming $116M-$121M full-year outlook
Sanara MedTech Inc. Common Stock · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · Now $21.92
+16% in 7d after detection
Post-detection moves
1h
—
1d
+3.2%
3d
+3.0%
7d
+16%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS